Inventor · disambiguated record
Kathrin Ute Jansen
Also filed as: JANSEN KATHRIN · JANSEN KATHRIN U · JANSEN KATHRIN UTE
74 granted patents·26 pending applications·914 citations·filing 1995–2025
99Inventor score
Top patents by PatentIndex Score
100 records- 0197US10550159B2Neisseria meningitidis composition and methods thereofPFIZER·Filed 2018·Granted Feb 4, 2020·11 cites·15 claims
- 0297US10196429B2Neisseria meningitidis composition and methods thereofPFIZER·Filed 2017·Granted Feb 5, 2019·12 cites·5 claims
- 0397US9187536B1Compositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2015·Granted Nov 17, 2015·19 cites·20 claims
- 0496US10982198B2Compositions and methods relating to a mutant Clostridium difficile toxinPFIZER·Filed 2018·Granted Apr 20, 2021·4 cites·17 claims
- 0596US10774117B2Compositions relating to a mutant clostridium difficile toxin and methods thereofWYETH LLC·Filed 2017·Granted Sep 15, 2020·6 cites·31 claims
- 0696US9724402B2Neisseria meningitidis composition and methods thereofPFIZER·Filed 2016·Granted Aug 8, 2017·22 cites·10 claims
- 0796US9561269B2Neisseria meningitidis compositions and methods thereofPFIZER·Filed 2015·Granted Feb 7, 2017·19 cites·12 claims
- 0896US9492559B2Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereofPFIZER·Filed 2015·Granted Nov 15, 2016·46 cites·45 claims
- 0996US8557548B2Compositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2013·Granted Oct 15, 2013·25 cites·21 claims
- 1095US11208633B2Compositions and methods relating to a mutant Clostridium difficile toxinPFIZER·Filed 2019·Granted Dec 28, 2021·3 cites·15 claims
- 1195US11090375B2Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereofPFIZER·Filed 2020·Granted Aug 17, 2021·7 cites·4 claims
- 1295US11077180B2Non-lipidated variants of Neisseria meningitidis ORF2086 antigensWYETH LLC·Filed 2019·Granted Aug 3, 2021·8 cites·2 claims
- 1395US10543267B2Neisseria meningitidis compositions and methods thereofPFIZER·Filed 2018·Granted Jan 28, 2020·11 cites·23 claims
- 1495US10226525B2Group B Streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereofPFIZER·Filed 2016·Granted Mar 12, 2019·18 cites·32 claims
- 1595US10183070B2Neisseria meningitidis compositions and methods thereofPFIZER·Filed 2018·Granted Jan 22, 2019·12 cites·11 claims
- 1695US9745354B2Compositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2014·Granted Aug 29, 2017·15 cites·28 claims
- 1795USRE46518ECompositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2016·Granted Aug 22, 2017·9 cites·48 claims
- 1895US8986710B2Neisseria meningitidis compositions and methods thereofPFIZER·Filed 2013·Granted Mar 24, 2015·26 cites·8 claims
- 1995US8900597B2Compositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2013·Granted Dec 2, 2014·15 cites·41 claims
- 2095US8481692B2Compositions relating to a mutant Clostridium difficile toxin and methods thereofSIDHU MANINDER K·Filed 2012·Granted Jul 9, 2013·30 cites·20 claims
- 2194USRE48862ECompositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2019·Granted Dec 28, 2021·3 cites·20 claims
- 2294US11160855B2Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereofPFIZER·Filed 2016·Granted Nov 2, 2021·7 cites·48 claims
- 2394US10597428B2Compositions relating to a mutant clostridium difficile toxin and methods thereofWYETH LLC·Filed 2019·Granted Mar 24, 2020·7 cites·20 claims
- 2494US9802987B2Immunogenic fusion polypeptidesPFIZER·Filed 2014·Granted Oct 31, 2017·17 cites·6 claims
- 2594USRE46376ECompositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2015·Granted Apr 25, 2017·9 cites·21 claims
- 2693USRE48863ECompositions relating to a mutant Clostridium difficile toxin and methods thereofWYETH LLC·Filed 2019·Granted Dec 28, 2021·3 cites·20 claims
- 2793US11135279B2Immunogenic compositions for use in pneumococcal vaccinesPFIZER·Filed 2020·Granted Oct 5, 2021·3 cites·6 claims
- 2893US10829521B2Neisseria meningitidis composition and methods thereofPFIZER·Filed 2019·Granted Nov 10, 2020·5 cites·1 claims
- 2993US10512681B2Non-lipidated variants of Neisseria meningitidis ORF2086 antigensWYETH LLC·Filed 2017·Granted Dec 24, 2019·12 cites·20 claims
- 3092US10946086B2Group B Streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereofPFIZER·Filed 2019·Granted Mar 16, 2021·5 cites·7 claims
- 3192US10888611B2Neisseria meningitidis compositions and methods thereofPFIZER·Filed 2016·Granted Jan 12, 2021·6 cites·27 claims
- 3292US10787652B2Compositions and methods relating to a mutant clostridium difficile toxinPFIZER·Filed 2013·Granted Sep 29, 2020·6 cites·17 claims
- 3392US9822150B2Neisseria meningitidis compositions and methods thereofPFIZER·Filed 2014·Granted Nov 21, 2017·17 cites·8 claims
- 3491US11730800B2Neisseria meningitidis compositions and methods thereofPFIZER·Filed 2020·Granted Aug 22, 2023·2 cites·21 claims
- 3591US11535652B2Compositions relating to a mutant clostridium difficile toxin and methods thereofWYETH LLC·Filed 2019·Granted Dec 27, 2022·2 cites·19 claims
- 3691US10813989B2Neisseria meningitidis compositions and methods thereofPFIZER·Filed 2019·Granted Oct 27, 2020·3 cites·19 claims
- 3790US10899802B2Neisseria meningitidis compositions and methods thereofPFIZER·Filed 2017·Granted Jan 26, 2021·4 cites·16 claims
- 3890US7001995B1Synthetic human papillomavirus genesMERCK & CO INC·Filed 2000·Granted Feb 21, 2006·32 cites·15 claims
- 3989US9757443B2Non-lipidated variants of Neisseria meningitidis ORF2086 antigensANDERSON ANNALIESA SYBIL·Filed 2011·Granted Sep 12, 2017·16 cites·11 claims
- 4088US11872274B2Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereofPFIZER·Filed 2021·Granted Jan 16, 2024·1 cites·16 claims
- 4188US6290965B1DNA encoding human papillomavirus type 6AMERCK & CO INC·Filed 2000·Granted Sep 18, 2001·33 cites·12 claims
- 4288US2025002875A1Compositions and methods relating to a mutant clostridium difficile toxinPFIZER·Filed 2024·Application pending·0 cites
- 4387US10653764B2Immunogenic compositions for use in pneumococcal vaccinesPFIZER·Filed 2016·Granted May 19, 2020·6 cites·3 claims
- 4487US2023391835A1Compositions relating to a mutant clostridium difficile toxin and methods thereofWYETH LLC·Filed 2022·Application pending·0 cites
- 4586US7482428B2Optimized expression of HPV 31 L1 in yeastMERCK & CO LTD·Filed 2007·Granted Jan 27, 2009·8 cites·14 claims
- 4684US8889145B2Immunogenic compositions of Staphylococcus aureus antigensWYETH LLC·Filed 2013·Granted Nov 18, 2014·6 cites·18 claims
- 4784US8568735B2Immunogenic compositions of Staphylococcus aureus antigensANDERSON ANNALIESA·Filed 2010·Granted Oct 29, 2013·12 cites·22 claims
- 4884US7976848B2Optimized expression of HPV 58 L1 in yeastMERCK SHARP & DOHME·Filed 2009·Granted Jul 12, 2011·6 cites·10 claims
- 4984US7744892B2Optimized expression of HPV 52 L1 in yeastMERCK SHARP & DOHME·Filed 2009·Granted Jun 29, 2010·6 cites·9 claims
- 5084US7700103B2Optimized expression of HPV 52 L1 in yeastMERCK & CO INC·Filed 2005·Granted Apr 20, 2010·6 cites·7 claims
Showing the top 50 of 100 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Kathrin Ute Jansen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →